Important pharmacy news and late-breaking industry information updated daily.

JAPhA study: Millions of additional vaccinations are given each year because of ready access at pharmacies

Many ALS patients cannot afford the $145,000 price of the drug edavarone (Radicava—Mitsubishi Tanabe) without insurance, but some insurance provider have denied access to the drug, even though it was approved by FDA last fall for treatment of the disease.

FDA Commissioner Scott Gottlieb discusses steps the agency is taking to address the tactics of some drug manufacturers to forestall expected generic entry. A generic drug developer generally needs 1,500 to 5,000 units of the brand drug to perform what are often relatively straightforward studies for FDA approval.

Aim is to improve safe and effective medications to patients worldwide

FDA approved on Wednesday lofexidine hydrochloride (Lucemyra—US WorldMeds) for the mitigation of withdrawal symptoms to facilitate abrupt discontinuation of opioids in adults.

While the annual conference focuses on opioid abuse, more programming on appropriate pain management was included this year

FDA has approved epoetin alfa-epbx (Retacrit—Hospira) as a biosimilar to epoetin alfa (Epogen/Procrit—Amgen) for the treatment of anemia caused by chronic kidney disease, chemotherapy, or use of zidovudine for individuals with HIV.

New guidelines focus on diagnosis, infection prevention, and more

Agency calling it an intermittent supply chain shortage

Top federal health officials on Monday defended President Donald Trump's plan to reduce drug prices Monday after critics charged it left out more aggressive measures Trump advocated when he was a presidential candidate.